Abstract
Radical nephrectomy (RN) is an established standard in the treatment of renal cell cancer. Surgical innovation has focused on preservation of residual renal function by way of partial nephrectomy (PN) in selected patients while reducing surgical invasiveness and preserving oncological efficacy. Yet, 25 % of patients undergoing kidney cancer surgery experience immediate postoperative complications, and the risk is higher in patients with preoperative chronic kidney disease (CKD). Key intraoperative risk factors of kidney injury include warm/cold ischemia, blood loss, effects of pneumoperitoneum, risk of rhabdomyolysis, and direct loss of nephron mass. Current standards of the biochemical assessment of residual renal function are suboptimal, as they do not allow direct assessment of remnant kidney function. Renal scintigraphic techniques may provide one method of assessing differential damage to each kidney, and tissue-specific biomarkers of ischemic kidney injury offer hope to add to the diagnostic and prognostic value to current methods.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
References
Chow W-H, Devesa SS, Warren JL, et al. Rising incidence of renal cell cancer in the United States. JAMA. 1999;281(17):1628–31.
Hollingsworth JM, Miller DC, Daignault S, et al. Rising incidence of small renal masses: a need to reassess treatment effect. J Natl Cancer Inst. 2006;98(18):1331–4.
Robson CJ, Churchill BM, Anderson W. The results of radical nephrectomy for renal cell carcinoma. J Urol. 1969;101(3):297–301.
Huang WC, Levey AS, Serio AM, et al. Chronic kidney disease after nephrectomy in patients with renal cortical tumours: a retrospective cohort study. Lancet Oncol. 2006;7(9):735–40.
Lau WK, Blute ML, Weaver AL, et al. Matched comparison of radical nephrectomy vs nephron-sparing surgery in patients with unilateral renal cell carcinoma and a normal contralateral kidney. Mayo Clin Proc. 2000;75(12):1236–42.
Fergany AF, Hafez KS, Novick AC. Long-term results of nephron sparing surgery for localized renal cell carcinoma: 10-year followup. J Urol. 2000;163(2):442–5.
Uzzo RG, Wei JT, Hafez K, et al. Comparison of direct hospital costs and length of stay for radical nephrectomy versus nephron-sparing surgery in the management of localized renal cell carcinoma. Urology. 1999;54(6):994–8.
Rini BI, Campbell SC, Escudier B. Renal cell carcinoma. Lancet. 2009;373(9669):1119–32.
Hollenbeck BK, Taub DA, Miller DC, et al. National utilization trends of partial nephrectomy for renal cell carcinoma: a case of underutilization? Urology. 2006;67(2):254–9.
Miller DC, Hollingsworth JM, Hafez KS, et al. Partial nephrectomy for small renal masses: an emerging quality of care concern? J Urol. 2006;175(3 Pt 1):853–7; discussion 858.
Simmons MN, Schreiber MJ, Gill IS. Surgical renal ischemia: a contemporary overview. J Urol. 2008;180(1):19–30.
Klatte T, Shariat SF, Remzi M. Systematic review and meta-analysis of perioperative and oncological outcomes of laparoscopic cryoablation versus laparoscopic partial nephrectomy for the treatment of small renal tumors. J Urol. 2013;191(5):1209–1217.
Dindo D, Demartines N, Clavien PA. Classification of surgical complications: a new proposal with evaluation in a cohort of 6336 patients and results of a survey. Ann Surg. 2004;240(2): 205–13.
Hakimi AA, Rajpathak S, Chery L, et al. Renal insufficiency is an independent risk factor for complications after partial nephrectomy. J Urol. 2010;183(1):43–7.
Porpiglia F, Fiori C, Bertolo R, et al. The effects of warm ischaemia time on renal function after laparoscopic partial nephrectomy in patients with normal contralateral kidney. World J Urol. 2012;30(2):257–63.
Parekh DJ, Weinberg JM, Ercole B, et al. Tolerance of the human kidney to isolated controlled ischemia. J Am Soc Nephrol. 2013;24(3):506–17.
Wiesenthal JD, Fazio LM, Perks AE, et al. Effect of pneumoperitoneum on renal tissue oxygenation and blood flow in a rat model. Urology. 2011;77(6):1508. e9–15.
Dunn MD, McDougall EM. Renal physiology. Laparoscopic considerations. Urol Clin North Am. 2000;27(4):609–14.
Kim EH, Larson JA, Figenshau M, et al. Perioperative complications of robot-assisted partial nephrectomy. Curr Urol Rep. 2014;15(1):377.
Weight CJ, Larson BT, Fergany AF, et al. Nephrectomy induced chronic renal insufficiency is associated with increased risk of cardiovascular death and death from any cause in patients with localized cT1b renal masses. J Urol. 2010;183(4):1317–23.
Meyer TW, Rennke HG. Progressive glomerular injury after limited renal infarction in the rat. Am J Physiol. 1988;254(6 Pt 2):F856–62.
Basile DP, Donohoe D, Roethe K, et al. Renal ischemic injury results in permanent damage to peritubular capillaries and influences long-term function. Am J Physiol Renal Physiol. 2001;281(5):F887–99.
Pagtalunan ME, Olson JL, Tilney NL, et al. Late consequences of acute ischemic injury to a solitary kidney. J Am Soc Nephrol. 1999;10(2):366–73.
Lo LJ, Go AS, Chertow GM, et al. Dialysis-requiring acute renal failure increases the risk of progressive chronic kidney disease. Kidney Int. 2009;76(8):893–9.
Newsome BB, Warnock DG, McClellan WM, et al. Long-term risk of mortality and end-stage renal disease among the elderly after small increases in serum creatinine level during hospitalization for acute myocardial infarction. Arch Intern Med. 2008;168(6):609–16.
Porpiglia F, Fiori C, Bertolo R, et al. Long-term functional evaluation of the treated kidney in a prospective series of patients who underwent laparoscopic partial nephrectomy for small renal tumors. Eur Urol. 2012;62(1):130–5.
Coca SG, Yalavarthy R, Concato J, et al. Biomarkers for the diagnosis and risk stratification of acute kidney injury: a systematic review. Kidney Int. 2008;73(9):1008–16.
Coca SG, Parikh CR. Urinary biomarkers for acute kidney injury: perspectives on translation. Clin J Am Soc Nephrol. 2008;3(2):481–90.
Mishra J, Ma Q, Prada A, et al. Identification of neutrophil gelatinase-associated lipocalin as a novel early urinary biomarker for ischemic renal injury. J Am Soc Nephrol. 2003;14(10): 2534–43.
Parikh CR, Jani A, Mishra J, et al. Urine NGAL and IL-18 are predictive biomarkers for delayed graft function following kidney transplantation. Am J Transplant. 2006;6(7):1639–45.
Parikh CR, Mishra J, Thiessen-Philbrook H et al. Urinary IL-18 is an early predictive biomarker of acute kidney injury after cardiac surgery. Kidney Int. 2006;70(1):199–203
Mishra J, Dent C, Tarabishi R, et al. Neutrophil gelatinase-associated lipocalin (NGAL) as a biomarker for acute renal injury after cardiac surgery. Lancet. 2005;365(9466):1231–8.
Devarajan P. Emerging biomarkers of acute kidney injury. Contrib Nephrol. 2007;156: 203–12.
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2015 Springer Science+Business Media New York
About this chapter
Cite this chapter
Thakar, C.V., Gaitonde, K. (2015). Kidney Function and Injury After Nephrectomy for Kidney Cancer. In: Thakar, C., Parikh, C. (eds) Perioperative Kidney Injury. Springer, New York, NY. https://doi.org/10.1007/978-1-4939-1273-5_13
Download citation
DOI: https://doi.org/10.1007/978-1-4939-1273-5_13
Published:
Publisher Name: Springer, New York, NY
Print ISBN: 978-1-4939-1272-8
Online ISBN: 978-1-4939-1273-5
eBook Packages: MedicineMedicine (R0)